New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 7, p. 881, doi. 10.3390/ph6070881
- By:
- Publication type:
- Article
Works matching IS 14248247 AND DT 2013 AND VI 6 AND IP 7
Results: 6
1
2
Protein-Based Blood Substitutes: Recent Attempts at Controlling Pro-Oxidant Reactivity with and Beyond Hemoglobin.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 7, p. 867, doi. 10.3390/ph6070867
- By:
- Publication type:
- Article
3
Role of Diuretics and Ultrafiltration in Congestive Heart Failure.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 7, p. 851, doi. 10.3390/ph6070851
- By:
- Publication type:
- Article
4
Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 7, p. 837, doi. 10.3390/ph6070837
- By:
- Publication type:
- Article
5
Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 7, p. 813, doi. 10.3390/ph6070813
- By:
- Publication type:
- Article
6
Voltage-Gated Calcium Channel Antagonists and Traumatic Brain Injury.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 7, p. 788, doi. 10.3390/ph6070788
- By:
- Publication type:
- Article